<DOC>
	<DOCNO>NCT00158652</DOCNO>
	<brief_summary>This multicentric randomized phase III trial compare conventional radiotherapy concomitant chemotherapy versus accelerate radiotherapy concomitant chemotherapy versus accelerate radiotherapy patient stage III-IV head neck squamous cell carcinoma . The main end point event free survival .</brief_summary>
	<brief_title>Accelerated Radiotherapy Concomitant Chemo-radiotherapy HNSCC</brief_title>
	<detailed_description>This multicentric randomized phase III trial compare conventional radiotherapy concomitant chemotherapy ( arm A ) versus middle accelerate radiotherapy concomitant chemotherapy ( arm B ) versus accelerate radiotherapy alone ( arm C ) patient stage III-IV head neck squamous cell carcinoma ( HNSCC ) . The main end point event free survival . The treatment Bras A : Conventional radiotherapy give daily , deliver 70 Gy 7 week ( 5 fraction 2 Gy per week ) chemotherapy : 5FU : 600 mg/m²/d , Paraplatin : 70 mg/m²/d , D1-4 D22-25 D43-46 Bras B : middle accelerate radiotherapy deliver 70 Gy 6 week chemotherapy : 5FU : 600 mg/m²/d , Paraplatin : 70 mg/m²/d , D1-5 D29-33 - first part : radiotherapy give daily deliver 40 Gy 4 week 20 fraction 2 Gy - second part : radiotherapy give twice daily `` concomitant boost '' deliver 30 Gy 20 fraction 2 week ( 1,5 Gy x 2 / day ) Bras C : accelerated radiotherapy give twice daily deliver 64.8 Gy 3.5 week 36 fraction 1.8 Gy</detailed_description>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Laryngeal Neoplasms</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx Stage IIIIV ( UICC 1997 ) : T2 , T3 T4 N0N3 T0 N2N3 Not resectable Karnofsky PS &gt; = 70 Renal/liver/cardiac function blood count compatible use paraplatin 5FU Informed consent sign Distant metastasis Contraindication concomitant chemotherapy History cancer History head neck radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Head neck squamous cell carcinoma</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>